|
|
Improving Therapeutic Options for Hypoxia-related Depression with an Animal Model |
| 1I01BX002908-01A1 |
RENSHAW, PERRY FRANKLIN |
VA |
2016 |
|
|
CAP-Ketamine for antidepressant resistant PTSD |
| 1I01CX001142-01A1 |
KRYSTAL, JOHN H |
VA |
2016 |
|
|
Remotely-Delivered Benefits Counseling for Service Connection Applicants |
| 1I01RX001319-01A2 |
ROSEN, MARC I |
VA |
2016 |
|
|
Microglial Mechanisms in Panic-PTSD |
| 2I01BX001075-04A1 |
SAH, RENU |
VA |
2016 |
|
|
Calmodulin kinase II inhibition as novel molecular treatment of hypertension |
| 5I01BX000163-07 |
GRUMBACH, ISABELLA MARIA |
VA |
2016 |
|
|
ASICs in the n. accumbens in depression-related synaptic plasticity and behavior |
| 5I01BX000741-06 |
WEMMIE, JOHN A |
VA |
2016 |
|
|
Modeling Individual Differences in PTSD |
| 5I01BX001374-04 |
WILSON, MARLENE A |
VA |
2016 |
|
|
Role of RGC-32 in gliosis |
| 5I01BX001458-03 |
RUS, HOREA |
VA |
2016 |
|
|
Mechanisms of Drug Induced Phospholipidosis |
| 5I01BX002021-04 |
SHAYMAN, JAMES ALAN |
VA |
2016 |
|
|
Regulation of VTA dopamine neurons by AMP kinase |
| 5I01BX002525-02 |
JOHNSON, STEVEN WILLIAM |
VA |
2016 |
